Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement.
Anath C LionelAshwath GurumurthiAhmed FetoohRami EldayaSairah AhmedSwaminathan P IyerLoretta J NastoupilJason WestinRanjit NairLuis FayadLuis MalpicaSudhakar TummalaChristopher FlowersSattva S NeelapuMichael L WangPreetesh JainPublished in: Leukemia & lymphoma (2024)